Vertex Pharmaceuticals (VRTX) Interest & Investment Income (2016 - 2026)
Quarterly Interest & Investment Income fell 2.63% to $114.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $484.8 million through Mar 2026, down 9.35% year-over-year, with the annual reading at $490.9 million for FY2025, 17.92% down from the prior year.
Vertex Pharmaceuticals' Interest & Investment Income history spans 18 years, with the latest figure at $114.8 million for Q1 2026.
- Interest & Investment Income came in at $114.8 million for Q1 2026, down from $121.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $181.2 million in Q1 2024 to a low of $1.6 million in Q1 2022.
- The 5-year median for Interest & Investment Income is $122.6 million (2023), against an average of $115.3 million.
- Year-over-year, Interest & Investment Income skyrocketed 7562.5% in 2023 and then plummeted 34.93% in 2025.
- Vertex Pharmaceuticals' Interest & Investment Income stood at $86.0 million in 2022, then skyrocketed by 108.72% to $179.5 million in 2023, then dropped by 28.58% to $128.2 million in 2024, then decreased by 4.91% to $121.9 million in 2025, then dropped by 5.82% to $114.8 million in 2026.
- Per Business Quant, the three most recent readings for VRTX's Interest & Investment Income are $114.8 million (Q1 2026), $121.9 million (Q4 2025), and $125.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | 19.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.80 Mn |
| Dec 31, 2025 | 121.90 Mn |
| Sep 30, 2025 | 125.70 Mn |
| Jun 30, 2025 | 122.40 Mn |
| Mar 31, 2025 | 117.90 Mn |
| Dec 31, 2024 | 128.20 Mn |
| Sep 30, 2024 | 132.20 Mn |
| Jun 30, 2024 | 156.50 Mn |
| Mar 31, 2024 | 181.20 Mn |
| Dec 31, 2023 | 179.50 Mn |
| Sep 30, 2023 | 167.90 Mn |
| Jun 30, 2023 | 144.70 Mn |
| Mar 31, 2023 | 122.60 Mn |
| Dec 31, 2022 | 86.00 Mn |
| Sep 30, 2022 | 46.20 Mn |
| Jun 30, 2022 | 10.80 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | 1.50 Mn |
| Dec 31, 2020 | 2.32 Mn |
| Sep 30, 2020 | 3.10 Mn |
| Jun 30, 2020 | 4.24 Mn |
| Mar 31, 2020 | 12.58 Mn |
| Dec 31, 2019 | 12.36 Mn |
| Sep 30, 2019 | 17.63 Mn |
| Jun 30, 2019 | 18.08 Mn |
| Mar 31, 2019 | 15.62 Mn |
| Dec 31, 2018 | 13.97 Mn |
| Sep 30, 2018 | 10.54 Mn |
| Jun 30, 2018 | 8.05 Mn |
| Mar 31, 2018 | 5.79 Mn |
| Dec 31, 2017 | -12.55 Mn |
| Sep 30, 2017 | -13.57 Mn |
| Jun 30, 2017 | -14.66 Mn |
| Mar 31, 2017 | -16.77 Mn |
| Dec 31, 2016 | -20.44 Mn |
| Sep 30, 2016 | -20.14 Mn |
| Jun 30, 2016 | -20.16 Mn |